“URGENT: Protect Your Investment – Why Target Corporation Investors Should Seek Legal Counsel Before the Securities Class Action Deadline”

Class Action Lawsuit Against Target Corporation Rosen Law Firm Files Class Action Lawsuit New York, Feb. 09, 2025 (GLOBE NEWSWIRE) – Rosen Law Firm, a global investor rights law firm, has announced the filing of a class action lawsuit on behalf of purchasers of common stock of Target Corporation (NYSE: TGT) between August 26, 2022…

Read More

“Revolutionizing the Future: dynaCERT’s $5 Million Non-Brokered Equity Offering Listed on Business Wire”

Revolutionizing the Future: dynaCERT Launches Private Placement Offering Private Placement Offering Details DynaCERT Inc. (TSX: DYA) (OTC: DYFSF) (FRA: DMJ) has recently announced a non-brokered private placement offering of up to 33,333,334 units at a price of $0.15 per unit, with aggregate gross proceeds of up to $5,000,000. Each unit will consist of one common…

Read More

InMed Signs Standby Equity Purchase Agreement

InMed Pharmaceuticals Announces Standby Equity Purchase Agreement Introduction Vancouver, British Columbia–(Newsfile Corp. – December 17, 2024) – InMed Pharmaceuticals Inc. (NASDAQ: INM) (“InMed” or the “Company”), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, announces it entered into a Standby Equity Purchase…

Read More

Bitcoin Takes the Lead as Ripple Outshines Solana: A Crypto Tale of Triumph

Welcome to the Bitcoin Roller Coaster! Bitcoin (BTC) started the week on the front foot, climbing close to $35,200 in early Monday trades following a net-positive weekend trading session. The world’s largest cryptocurrency reacted positively to Friday’s underwhelming US data reads, which showed the unemployment rate creeping higher than expected with 150,000 new jobs added…

Read More

Plus Therapeutics Presents Leptomeningeal Metastases Programs at 2024 SNO Annual Meeting in Houston, Texas

Company to Present Results from Phase 1 Clinical Trial of Rhenium (186Re) Obisbemeda for Leptomeningeal Metastases AUSTIN, Texas, Oct. 29, 2024 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV), a clinical-stage pharmaceutical company developing targeted radiotherapeutics for CNS cancers, will be presenting data at the 2024 Society for Neuro-Oncology (SNO) Annual Meeting in Houston, Texas….

Read More

Vonage Partners with Meta to Enable Secure and Instant Payments through WhatsApp in Singapore

Vonage Partners with Meta to Enable Secure and Instant Payments through WhatsApp in Singapore Description: Vonage Conversational Commerce, Powered by Jumper.ai, Enables Full Messaging-First eCommerce for Customers SINGAPORE–(BUSINESS WIRE)–Vonage, a global leader in cloud communications helping businesses accelerate their digital transformation, has partnered with WhatsApp as a Business Solution Provider, to launch payments on the…

Read More

“Uncovering the Truth: Groupon (GRPN) Rises, But Falls Short of Market Expectations – Here’s What You Need to Know”

Groupon’s Recent Trading Session at $11.76 A Closer Look at Groupon’s Stock Price Recently, Groupon (GRPN) concluded the trading session at $11.76, showing a slight increase of +0.09% from its previous day’s closing price. This news may not seem significant at first glance, but it provides valuable insights into the company’s current standing in the…

Read More

“Unpacking Pegasystems Inc.’s Q4 2024 Earnings Call: A Playful, Quirky, and Relatable Recap for Our Blog Readers”

Welcome to the Pegasystems Inc. Q4 2024 Earnings Conference Call! Get ready for some exciting insights! As we gear up for the Pegasystems Inc. Q4 2024 Earnings Conference Call, we can’t help but feel the buzz of anticipation in the air. With a stellar lineup of key speakers including Peter Welburn, Alan Trefler, and Kenneth…

Read More